Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer The study included 523 patients from 23 centers in four French ...

In peritoneal cancer, cancer cells grow within the serous membrane, a component of the peritoneal cavity. There are two main types of peritoneal cancer: primary and secondary. Primary peritoneal ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

Even if gastric cancer spreads to the abdominal cavity and becomes terminal, treatment should not be abandoned. A study found ...

Drug delivery systems can alter drug clearance from the peritoneal cavity and drug toxicity profiles. For example, IP injection of cisplatin-loaded polymeric microspheres (100–200 µm, which releases ...

Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. This systematic review evaluates the available evidence about adjuvant (hyperthermic) intraperitoneal ...

In patients with tumors confined to the peritoneal cavity, there is established pharmacokinetic and tumor biology-related evidence that intraperitoneal drug administration is advantageous. Three large ...

Please provide your email address to receive an email when new articles are posted on . The addition of intraperitoneal paclitaxel to systemic capecitabine and oxaliplatin appeared to benefit patients ...

My daughter, age 44, has had chronic kidney disease since she was 10 years old. She had a renal transplant at 23, then ...

Since patients with peritoneal metastases often also have distant metastases in systemic organs, intravenous therapy is usually the standard of care. Multiple clinical studies have shown that adding ...

PPC is a type of cancer that starts in the peritoneal cavity in the abdomen, rather than cancer that has developed elsewhere in the body and spread to the peritoneum. Cancer that has started elsewhere ...